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Mesenchymal stem cells are showing increasing promise in applications such as tissue engineering and cell therapy. MSC are low
in number in bone marrow, and therefore in vitro expansion is often necessary. In vivo, stem cells often reside within a niche acting
to protect the cells. These niches are composed of niche cells, stem cells, and extracellular matrix. When blood vessels are damaged,
a fibrin clot forms as part of the wound healing response. The clot constitutes a form of stem cell niche as it appears to maintain
the stem cell phenotype while supporting MSC proliferation and differentiation during healing. This is particularly appropriate
as fibrin is increasingly being suggested as a scaffold meaning that fibrin-based tissue engineering may to some extent recapitulate
wound healing. Here, we describe how fibrin modulates the clonogenic capacity of MSC derived from young/old human donors
and normal/diabetic rats. Fibrin was prepared using different concentrations to modulate the stiffness of the substrate. MSC were
expanded on these scaffolds and analysed. MSC showed an increased self-renewal on soft surfaces. Old and diabetic cells lost the
ability to react to these signals and can no longer adapt to the changed environment.
1. Introduction
Adult tissue stem cells are thought to be involved in tissue
maintenance and repair processes. When numbers are low,
tissue stem cells are replenished by mesenchymal stem cells
(MSC) via the blood system [1]. Depletion of the stem
cell population has been suggested to contribute to a large
number of degenerative diseases of brain, liver, skin, bone
and plays a role in many aging-related diseases [2]. MSC
reside in the bone marrow and can differentiate into a variety
of tissues including bone, fat, and cartilage in vitro and in vivo
[3, 4]. MSC are therefore ideal candidates for use in tissue
engineering and cell therapy. MSC are particularly attractive
because of the ease of isolation and manipulation.
It has been demonstrated that MSC ex vivo exhibit the
characteristics typical of the Hayflick model of cellular senes-
cence with a limited life span and in addition telomere short-
ening, accumulation of β-galactosidase [5], and impairment
of differentiation [6]. Increased resistance to in vitro aging
and extended expansion would be desirable characteristics
for improved tissue engineering and cell therapy especially
for the elderly. Several attempts to delay in vitro aging have
been performed including reductions in oxygen level, tem-
perature, glucose [7], genetic manipulation [8], and telom-
erase overexpression [9].
Many surfaces and scaffolds have been extensively
evaluated for tissue engineering purposes. The effect of
the mechanical stimulation of a particular surface on the
behavior of MSC has been studied for a variety of potential
differentiation effects. Mechanical stimulation either by
vibrating cells, stretching cells or by providing surfaces
with different mechanical properties can induce osteogenic
differentiation or inhibit adipogenesis [10] through durable
b-catenin activation [11].
Fibrin is a biodegradable polymer that is being increas-
ingly used in tissue engineering applications and is showing
promise as an alternative scaffold in vascular tissue engineer-
ing [12, 13] and skin [14]. Under physiological conditions,
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a fibrin clot is formed after trauma and the fibrin is respon-
sible for most of the biological and mechanical properties of
the blood clot [15]. The mechanical properties of fibrin clots
are particularly important as they serve as both gap fillers to
prevent bleeding and as a mechanical support to stabilise the
wound. Because of this fibrin clots are remarkably extensible
and elastic. The use of fibrin as a tissue engineering scaffold
would therefore seem highly appropriate as in many ways
the tissue engineering process could be considered to be a
reiteration of the wound healing process.
Although a role in wound healing has been suggested
for MSC, there is little direct biological evidence to support
this. It has been suggested that fibrin can act as a form of
“stem cell niche” for endothelial progenitor cells [10], and it
would seem logical that this might also be the case withMSC.
It is known that MSC can travel through the circulation
and become incorporated into transplanted tissues [16–18]
and fibrin has been shown to be highly haptotactic for a
number of mesenchymal cell types including MSC [19, 20].
Research has been completed demonstrating that MSC are
able to adhere, spread, and proliferate when seeded into
a fibrin gel with low thrombin to fibrinogen ratios [21].
Stromal cells do not contract the fibrin and the material
has no toxic effect on lapine MSC [11]. In addition fibrin
can be isolated from the same donor as the MSC would
therefore be a good material for clinical translation of cell
preparations as the whole procedure would be performed
using autologous material. However, there is lack of available
data looking at the effects fibrin has on MSC growth and
differentiation behaviour. We investigated the effect of fibrin
on MSC from normal and diabetes type I rats as well as MSC
from young and aged human donors. It is known that MSC
from diabetic [22] and old donors [23, 24] do expand less in
vitro and show earlier senescence. The aim was to establish
a surface minimising in vitro aging and with good growth
and differentiation potential. Growth and differentiation was
evaluated on fibrin scaffolds with a range of stiffnesses to
identify the optimal concentration of fibrin to support MSC.
2. Materials and Methods
2.1. Chemicals. All chemicals were obtained from Sigma-
Aldrich (Dorset, UK) unless otherwise stated and used
without further purification.
2.2. Cell Culture. Dulbecco’s Modified Eagle Medium (Cam-
brex Bio Science, Workingham, UK) was supplemented
with 10% Serum Supreme (Cambrex Bio Science, Work-
ingham, UK), 1% Ultraglutamine (BioWhittaker, UK), and
1% penicillin-streptomycin solution and will hereafter be
referred to as growth medium. For osteogenic differentia-
tion cells were cultured in growth medium supplemented
with dexamethasone (10−8 M) and ascorbate-2-phosphate
(50 μg/mL).
2.3. Mesenchymal Stem Cells. Wistar rats were purchased
from Harlan (Bicester, UK) and kept on site according to
home office regulations. To induce type I diabetes rats were
injected with a single dose of streptozotocin (STZ 65mg/kg
body weight) in ice-cold 0.01M sodium citrate buffer (pH
4.5) at 3-month old. Rats were allowed food and water ad
libitum. Bodyweights were monitored weekly, along with
urine glucose levels. Blood glucose levels were determined at
the time of death. Rats of a similar age were used as healthy
comparisons. Bone marrow cells were obtained centrifugally
from tibiae and femurs according to the method of Dobson
et al. [25] and MSC isolated by the method of Sekiya et al.
[26].
Human MSC were purchased from Tulane University
(Emeryville, Calif, USA) or AllCell (Emeryville, Calif, USA).
MSC isolated from donors aged between 18–25 were classi-
fied as young whilst MSC isolated from donors aged 55–60
were classified as old.
2.4. Immunophenotyping of Mesenchymal Stem Cells. To
confirmMSC phenotype, humanMSCwere harvested after 7
days and stained with antibodies against CD11, CD31, CD44,
CD45, CD90, CD105, D7fib, and stro-1 (diluted 1 : 100; 4◦C;
30min; Serotec, Oxford, UK). Rat MSC were stained for
CD11, CD44, CD45, CD90, and CD105. Cell phenotyping
and cell size were performed using a personal flow cytometry
system (GUAVA Instruments, Hayward, USA, or an Acuri
FACS).
2.5. Demonstration of Differentiation Potential of Mesenchy-
mal Stem Cells. 20,000 cells were seeded in 24-well plates
and incubated in osteogenic medium (containing 10−8 M
dexamethasone and 50 μg/mL ascorbate-2-phosphate for
14 days. MSC were fixed and stained histochemically for
alkaline phosphatase activity. Briefly, MSC were incubated
for 30min at room temperature in a solution of naphthol AS-
BI phosphate (0.05mg/mL) in Tris buffer (0.08M, pH 7.5)
containing fast red bb or fast violet (1mg/mL), washed, and
photographed. For adipogenic differentiation 20,000 cells
were seeded in 24-well plates and incubated in adipogenic
differentiation medium (1mM dexamethasone, 5mg/mL
insulin, 0.5mM isobutylmethylxanthine (IBMX), 60mM
indomethacin) for 14 days. Cells were fixed with isopropanol
and stained with oil red O solution to detect the presence of
neutral lipid vacuoles and photographed.
2.6. Production of the Fibrin Scaffolds. Fibrinogen type I from
bovine plasma was dissolved in medium at 37◦C for a range
of concentrations (3, 10, and 30mg/mL). The mixture was
gently agitated until the fibrinogen dissolved and then cooled
by refrigeration. Thrombin from bovine plasma was added
(1 unit/mL) to induce gelation. 5mL was added to each
25 cm2 culture flask. Flasks were incubated at 37◦C for 1 h
and rinsed with PBS before use. The MSC were seeded on
top of the fibrin scaffold.
2.7. Colony-Forming Unit Fibroblastic Assay. To determine
proliferation capacity and maintenance of differentiation
potential the colony-forming unit fibroblast assay was
employed as a modification of the technique originally
described by Kuznetsov et al. [27]. Primary MSC were
cultured on fibrin gels (3, 10 and 30mg/mL) and tissue
culture plastic (TCP) controls for 7 days. 1000 cells were then
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Figure 1: MSC validation. MSC isolated from humans and rats were immunophenotyped using typical MSC marker (Figures 1(a) and
1(b)), and the stem cell potential was confirmed by differentiating them into adipocytes and osteoblasts (Figures 1(c) and 1(d)).
transferred to 55-cm2 plates and cultured for a subsequent
14 days in osteogenic medium. At this point colonies were
fixed in ethanol, sequentially stained for alkaline phosphatase
and total colonies and photographed as previously described
[28].
2.8. Colony Analysis. Colony numbers were assessed using
the method of Dobson et al. [25]. Briefly, the acquired digital
images were imported into Photoshop, colony irregularities
smoothed out and converted into a 256-level greyscale
format. The greyscale images were then imported into
Bio-image “Intelligent Quantifier” and the colony number
calculated.
2.9. Data Analysis. Values were expressed as mean ± stan-
dard deviation of three experiments. Comparison of results
was performed by one-way analysis of variance (ANOVA)
and multiple comparisons made using Tukey’s test. Data was
considered significantly different when P < 0.05.
3. Results
3.1. Clonogenic and Osteogenic Differentiation Potential of
Healthy and Diabetic Rat Mesenchymal Stem Cells after
Preculture on Fibrin. MSC were isolated from normal or
streptozotocin type I diabetic rats (2-3-month old) and
their phenotype confirmed by flow cytometric analysis. Cells
were CD44 and CD90 positive, CD45 low, and negative
for CD11 (Figure 1(a)). The cells were able to differentiate
into adipocytes and osteoblasts under appropriate culture
conditions (Figure 1(b) and 1(c)).
To determine the effects on the clonogenicity and reten-
tion of differentiation potential of culturing MSC on three-
dimensional fibrin scaffolds with physiologically relevant
elastic moduli, freshly isolatedMSCwere cultured on 3, 10 or
30mg/mL fibrin and on TCP for 7 days before transferring
1000 cells to uncoated Petri dishes and culturing for a
further 14 days in osteogenic growth medium. We found
that MSC derived from young rats showed increased CFU-
f frequencies compared to MSC derived from rats 12 weeks
after streptozotocin injection.
Frequency of ALP colonies was significantly increasing
on fibrin in comparison to TCP (Figure 2(a)) but the average
colony size was not affected (Figure 2(b)). The same was
observed for the frequency of total colonies (Figure 2(c)) and
the average colony size of these (Figure 2(d)). The initially
lower colony numbers from diabetic rats was not modulated
by culturing on fibrin and the same trend was found with
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Figure 2: Effects of fibrin surfaces on healthy and diabetic rat MSC. MSC isolated from young and diabetic rats were grown on fibrin gels
for 7 days, and then 1000 cells were seeded into the CFU assays under osteogenic conditions. ALP-positive (grey) and total colony numbers
(black) were calculated for normal rat MSC (a) as well as the mean size of the colonies (b). CFU numbers for MSC from were also calculated
(c) as well as the mean colony size (d). ∗Denotes a statistically significant difference from the other groups.
regards to the CFU size (total colony count) and the number
and size of the ALP-positive colonies (Figures 2(b) and 2(d)).
3.2. Clonogenic and Osteogenic Differentiation Potential
between Old and Young Human Mesenchymal Stem Cells.
Young MSC were isolated from 18–25-years-old donors and
old MSC from donors aged between 55 and 60 years. Cell
phenotype was confirmed by flow cytometric analysis. Cells
were CD44, CD90, stro-1, and D7fib positive and CD11,
CD31, and CD45 low (Figure 1(d)). The cells were able
to differentiate into osteoblasts and adipocytes under the
appropriate culture conditions (Figures 1(e) and 1(f)).
The number of colonies of expanded young human MSC
was positively linked to the softness of the fibrin substrate.
MSC were cultured on the different surfaces and then
reseeded onto TCP for the CFU-f assay. The number of ALP-
positive colonies increased significantly after culture on 3 and
10mg/mL fibrin relative to TCP (Figure 3(a)). Total colony
numbers followed the same trend; however only the 3mg/mL
fibrin leads to a significant increase in colony numbers. The
size of colonies was slightly but not significantly increased
when expanded on 10mg/mL fibrin gels (Figure 3(b)).
3.3. Response of Old MSC Cultured on Fibrin. In general
the number of CFU derived from cultured MSC from old
donors is much lower compared to the MSC from young
donors (Figure 3). Interestingly, we see the opposite trend
for CFU numbers using old MSC expanded on the different
surfaces compared to youngMSC.We find significantly more
colonies on TCP and less on the softer surfaces, with no
difference between fibrin concentrations. The trend is not
significant for ALP-positive colonies but for total colonies.
For MSC from aged donors we find ∼50% ALP-positive
colonies compared to MSC from young donors. Total colony
numbers are decreased by ∼40%. If we compare this to the
fibrin concentration which gave the highest CFU numbers
with the MSC from young donors we find a much greater
decrease. On 3mg/mL fibrin we only find 5% ALP-positive
colonies and ∼10% total colonies using MSC from aged
donor. Colony sizes were also slightly larger on plastic and
the 30mg/mL fibrin but did not reach significance (Figures
3(b) and 3(d)). Also the old MSC do become smaller on
the fibrin surfaces on all tested concentrations (Figures 4(c)–
4(h)). On the plastic they have an enlarged morphology
typical for senescent MSC, and on the highest concentrated
fibrin gel we find them to be much smaller and highly
aligned (Figures 4(f) and 4(h)). MSC on the other two
concentrations followed the same pattern as MSC from
young donors (data not shown).
3.4. Effect of Fibrin on Expansion and Differentiation of Sec-
ondary Mesenchymal Stem Cells. To assess whether the effect
of substrate stiffness on the clonogenic potential of MSC
was still present after an initial expansion on the 10mg/mL
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Figure 3: Effects of fibrin surfaces on young and old human MSC. Isolated MSC from young donors and aged donors were grown on fibrin
gels for 7 days, and then 1000 cells were seeded into the CFU assays under osteogenic conditions. The number of ALP-positive colonies (grey)
and total colony numbers (black) were calculated for young (a) and aged (c) MSC. Mean sizes of colonies were calculated for young (b) and
aged (d) donor MSC. ∗Denotes a statistically significant difference from the other groups.
fibrin preparation (showing the highest CFU-f numbers),
MSC were re-seeded onto the different fibrin substrates (3–
30mg/mL) to see if the cells retained the influence by the first
substratum. Secondary MSC followed the same trend as the
primaryMSC. An increase in the number of colonies per dish
after preculture on the fibrin compared to the TCP control
was observed; however this time also the 10mg/mL fibrin-
cultured MSC showed a significant difference in comparison
to TCP-cultured MSC (Figure 4(a)). However, unlike the
primary human MSC, no difference in colony size was seen
between the different groups (Figure 4(b)).
3.5. Morphological Comparison. MSC cultured on fibrin
changed their morphology according to the fibrin softness
(Figures 4(c)–4(h)). The cell size was reduced on all fibrin
surfaces. This was confirmed by analysing cell size by
flow cytometry (Table 1). On the 30mg/mL fibrin, and
to a lesser extent on the 10mg/mL fibrin, the MSC were
highly aligned. Furthermore, on the 3mg/mL surfaces the
cells started to form networks. As this hinted towards a
potential better self-renewal we cultured these MSC for one
passage on the different fibrin concentrations and analysed
second-generation colony formation. The MSC cultured on
plastic lost about 90% of their colony-forming capacity. The
frequency of CFU could be increased by a factor of about 5
Table 1: Cell size grown on fibrin. Fibrin gels were made by
mixing fibrinogen (3, 10, and 30mg/mL) with thrombin (1 μl/mL).
Different MSC types were analysed for cell sizes.
Cell type Abitary units
Young rMSC 329± 136
Diabetic rMSC 392± 150
Young rMSC (30mg/mL) 420± 10
Young hMSC 408± 51
Aged hMSC 420± 57
Aged hMSC (30mg/mL) 344± 127
when the cells were cultured on 3mg/mL fibrin; however no
effect on proliferation rates was seen (Figures 4(a) and 4(b)).
3.6. Effect of Fibrin Concentration on Gel Stiffness. One pos-
sible factor contributing to the effects of fibrin concentration
on MSC clonogenic capacity is its effects on fibrin gel
stiffness. To determine the effect of fibrin on gel stiffness a
stress strain plot was calculated using a Bose Electroforce
3200 (Figures 5(a)–5(c)). As no linear region was found,
the stiffness was measured using a tangent modulus at 20%
strain. The data showed that as the concentration of fibrino-
gen increased so did the stiffness with a modulus of 16.7 kPa
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Figure 4: MSC morphology and self-renewal. MSC from an 18-year-old healthy donor were cultured on 10mg/mL fibrin for 7 days before
re-seeding them onto different concentrations of fibrin or TCP. We call these secondary colonies. The different surfaces were again tissue
culture plastic, 3mg/mL fibrin gel, 10mg/mL, and 30mg/mL (d). MSC from a 55-year-old donor are cultured on TCP and 30mg/mL fibrin
gel. Colony numbers (a) as well as size (b) are shown and the different morphologies (c–h) are shown. ∗Denotes a statistically significant
difference from the other groups.
for 3mg/mL, 40.4 kPa for 10mg/mL, and 77 kPamg/mL for
30mg/mL. The stiffness of the 30mg/mL gel was statistically
difference from the 3 and 10mg/mL gel (Figure 5(d)).
4. Discussion
MSC are becoming increasingly popular for tissue engineer-
ing and cell-based therapies due to the ease of isolation and
cultivation. Their immunomodulatory functions as well as
their secretome make them an ideal source for therapies.
However in vitro expansion is needed to expand numbers,
as MSC occur in low numbers (1 of 100,000 cells) in
bone marrow [29] and decline in frequency with age [24].
Expansion leads to in vitro aging of the MSC accompanied
with a declining proliferation and differentiation potential
[30]. Aged MSC express markers typical of aged somatic
cells including increased p53 and p21 levels [31], have
a changed morphology [3], and express the senescence
marker β-galactosidase [23]. Clinical use of aged MSC could
lead to serious side effects as it is known that senescent
cells can induce cancer formation [32]. Human adipose-
tissue-derived mesenchymal stem cells can spontaneously
transform when they reach senescence [33]. Because of
this, it is necessary to keep the numbers of senescent cells
present in tissue-engineered constructs as low as possible
and to minimize senescence during expansion. It is now well
acknowledged that stem cells interact with their environment
[34]. Manipulation of stem cell behaviour by changing the
niche of the stem cells is possible. Extracellular matrix
components are part of the stem cells niche. Fibrin is a
natural biodegradable polymer increasingly used in tissue
engineering and can be produced autologously and is
therefore a good choice of scaffold for potential therapeutic
applications. It is widely used in cartilage tissue engineering
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Figure 5: Tangent modulus of a range of fibrin gel produced with varying fibrinogen concentrations. Fibrin gels were made by mixing
fibrinogen (3, 10, and 30mg/mL) with thrombin (1 μl/mL). Tensile testing of the gels was performed using a Bose ElectroForce 3200 (a–c).
The tangent moduli were calculated from the slope of the plot of stress versus strain at 20% strain (n = 6) (d).
[35] and can be rapidly degraded by plasmin. It is therefore
an ideal candidate for in vitro expansion of MSC and could
also be used for transplantation to protect and modulate
MSC behaviour.
Fibrin gels with various fibrinogen concentrations were
made with different mechanical properties (different Young’s
moduli). MSC were seeded onto these gels and cultured
before being analysed. We found that MSC from young rats
andMSC from young humans responded to the different fib-
rinogen concentrations. The highest self-renewal measured
using the CFU-f assay capacity was found on the softest fibrin
surfaces. This effect however was lost for MSC from either
diabetic Type I rats or aged human donors. We know from
former studies that CFU-f numbers from diabetic rats and
aged humans [24] were lower compared to young healthy
controls. This is now confirmed for the frequency of culture-
expanded MSC with the same trends observed. The use of
the CFU-f as an assay to determine the number of MSC
present in a cell preparation has been well characterised [25],
with the assumption that each colony arises from a single cell
allowing for the number of colonies to be correlated to the
number of stem cells in the original sample. Fibrin gels seem
to alter the frequency of stem cells in the MSC cultures and
can increase in young MSC the number of MSC with an high
proliferative and differentiation potential. MSC cultured on
fibrin appeared to align along the same axis whereas on TCP
they had a typical “cobble-stone-” like appearance. Not only
were differences seen in the morphology of the cells but also
the size of the cell was different. It is well accepted that
an increase in cell size is linked to senescence of the cell
and thereby suggests that smaller cells are “younger” than
the larger ones [23]. The MSC from old donors decreased
in size after culturing on the soft fibrin surface, maybe
due to matrix-induced rejuvenation effects. In fibroblasts
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the senescence phenotype could be reversed by altering cell
attachment via the inhibition of calveolin-1 [36].
It was observed that not only CFU-f efficiency, but also
the number of colonies that stained positive for ALP was
higher after pre-culture on the softer substrates for cells from
young and nondiseased donors. This data suggests that pre-
culturing on the softer substrates maintains a more “stem-
cell-” like phenotype. A study investigating maintenance
of human MSC phenotype has implicated the basement
membrane ECM as a critical factor in the proliferative
life span and maintenance of differential potential of stem
cells in culture and highlights the importance of a native,
soft substratum for maintaining a more “stem cell-” like
phenotype and showed greater effects than growth factors
like fibroblastic growth factor [37]. Studies on the effect of
temperature on MSC from old donors showed the same
reduced response to an environmental challenge [38]. Pro-
teomic studies on human agedMSC showed that antioxidant
and cytoskeleton functions are diminished in agedMSC [39].
The beneficial effects of surfaces on the “stemness” properties
could be mediated via the cytoskeleton, or due to changes
in the signal transduction pathway. Cell shape was shown
to regulate stem cell differentiation [40]. The Rho family
of small GTPases transmit signals from the extracellular
matrix to the actin skeleton and the nucleus, modulating
gene expression [36, 41]. Receptors involved in the signal
transmission are integrins, dystroglycans, syndecans, CD44,
and Rhamm. Such signals can lead to dramatic changes in
cell morphology and cell architecture involving cytoskeleton
and chromatin structures, affecting gene expression [42].
Lamins making up the nuclear envelope are connected to
the actin filaments through nespin, anchoring the nucleus to
the cytoskeleton. Disruption of actin leads to global histone
deacetylation and cells rounding up [43].
Outlook. This is the first report of the self-renewal potential
of expanded MSC from aged and diseased donors on fibrin
scaffolds. We have shown that young MSC maintain a better
self-renewal on soft fibrin gel, but this benefit is partly
lost when cells from aged or diabetic organisms are used.
Additional modifications of the scaffolds might be necessary
to gain the same effects seen in young MSC.
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